EcoDrugPlus

Solute Carrier Family 6 Member 4

Ensembl ID : ENSBGRG00000018708
Gene Symbol: SLC6A4
1 Cross references
205 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSBGRG00000018707
Gene Symbol: SLC6A9
1 Cross references
198 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSBGRG00000021848
Gene Symbol: SLC9A3
1 Cross references
238 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSBGRG00000004681
Gene Symbol: SSTR1
1 Cross references
160 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSBGRG00000026504
Gene Symbol: SSTR2
1 Cross references
264 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSBGRG00000006556
Gene Symbol: SSTR3
1 Cross references
251 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSBGRG00000007134
Gene Symbol: SSTR5
1 Cross references
257 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSBGRG00000020624
Gene Symbol: SPHK2
1 Cross references
209 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSBGRG00000009215
Gene Symbol: S1PR1
1 Cross references
194 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSBGRG00000017500
Gene Symbol: SYK
1 Cross references
203 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSBGRG00000006337
Gene Symbol: SRD5A2
1 Cross references
266 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSBGRG00000008706
Gene Symbol: SOAT1
1 Cross references
211 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).